SPAC13G7.11 Antibody

What is SPAC13G7.11 and what is its biological function?

SPAC13G7.11 is a gene in the fission yeast Schizosaccharomyces pombe that encodes a protein involved in aerobic respiration pathways . It is functionally associated with other respiratory proteins including components of the electron transport chain and mitochondrial proteins. The protein functions as part of the metabolic network that regulates energy production in yeast cells, particularly under aerobic conditions. Understanding this protein's role provides insights into conserved respiratory mechanisms that may have parallels in higher eukaryotes.

How can I validate the specificity of a SPAC13G7.11 antibody?

Validating antibody specificity requires multiple complementary approaches:

• Genetic validation: Test the antibody in wild-type and SPAC13G7.11 knockout strains. A specific antibody will show signals in wild-type cells but not in knockout cells .

• Western blot analysis: Perform immunoblotting with cell lysates from wild-type and knockout strains. A specific band at the predicted molecular weight should appear only in wild-type samples .

• Immunoprecipitation followed by mass spectrometry: This approach confirms that the antibody captures the intended target protein. The primary protein identified in IP-MS should be SPAC13G7.11 .

• Cross-reactivity testing: Test the antibody against related yeast proteins to ensure specificity within the respiratory protein family .

• Epitope mapping: Determine which region of SPAC13G7.11 is recognized by the antibody, which helps in understanding potential cross-reactivity and functional blocking capabilities .

What are the optimal conditions for using SPAC13G7.11 antibody in Western blotting?

When performing Western blotting with SPAC13G7.11 antibody, consider these optimized conditions:

The above conditions should be optimized for each specific antibody preparation and experimental requirement .

How can I perform successful immunoprecipitation with SPAC13G7.11 antibody?

For successful immunoprecipitation of SPAC13G7.11:

• Cell lysis: Use a gentle lysis buffer (e.g., 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40, protease inhibitors) to maintain protein-protein interactions.

• Pre-clearing: Incubate lysate with Protein A/G beads for 1 hour at 4°C to reduce non-specific binding.

• Antibody binding: Add 2-5 μg of SPAC13G7.11 antibody to 500 μg-1 mg of pre-cleared lysate and incubate overnight at 4°C with gentle rotation.

• Precipitation: Add 30-50 μl of fresh Protein A/G beads and incubate for 2-4 hours at 4°C.

• Washing: Perform at least 4 washes with decreasing salt concentration to remove non-specific interactions while preserving specific binding.

• Elution: Use either acidic conditions, denaturing buffer, or peptide competition depending on downstream applications.

This protocol can be further optimized by using crosslinking approaches if the interactions are transient, as demonstrated in research with other yeast proteins .

How can I combine SPAC13G7.11 antibody with other techniques to study protein-protein interactions?

Several advanced approaches can be used in combination with SPAC13G7.11 antibody:

• Co-immunoprecipitation with crosslinking: Use formaldehyde (1%) to stabilize transient interactions before immunoprecipitation with SPAC13G7.11 antibody. This method has been successful in detecting interactions in other fission yeast proteins .

• Proximity ligation assay (PLA): Combine SPAC13G7.11 antibody with antibodies against suspected interacting partners to visualize interactions in situ.

• ChIP-Seq analysis: If SPAC13G7.11 interacts with DNA or chromatin-associated proteins, use the antibody for chromatin immunoprecipitation followed by sequencing.

• FRET microscopy: Combine immunofluorescence using SPAC13G7.11 antibody with fluorescent protein tags on potential interaction partners.

• BiFC (Bimolecular Fluorescence Complementation): Express SPAC13G7.11 and potential interactors with split fluorescent protein tags and use the antibody to confirm expression levels.

These techniques can provide complementary data on protein-protein interactions in their native cellular context .

How can I use SPAC13G7.11 antibody to study post-translational modifications?

To study post-translational modifications (PTMs) of SPAC13G7.11:

• Phosphorylation analysis: Immunoprecipitate SPAC13G7.11 using the specific antibody, then perform Western blot with phospho-specific antibodies (anti-phosphoserine, anti-phosphothreonine, anti-phosphotyrosine) .

• Mass spectrometry after IP: Immunoprecipitate SPAC13G7.11 and analyze by mass spectrometry to identify multiple PTMs simultaneously .

• 2D gel electrophoresis: Combine with Western blotting to separate different phosphorylated forms of the protein.

• Phos-tag SDS-PAGE: Use this specialized gel system with SPAC13G7.11 antibody for Western blotting to separate phosphorylated from non-phosphorylated forms.

• In vitro kinase assays: Purify SPAC13G7.11 by immunoprecipitation and use it as a substrate in kinase assays with suspected regulatory kinases.

Research in fission yeast has demonstrated that similar respiratory proteins undergo phosphorylation in response to metabolic changes, suggesting SPAC13G7.11 may be similarly regulated .

What are common issues when using SPAC13G7.11 antibody and how can they be resolved?

These solutions are based on established protocols for mitochondrial and respiratory chain proteins in yeast systems .

How can I optimize fixation conditions for immunofluorescence with SPAC13G7.11 antibody?

Optimizing fixation for mitochondrial proteins in yeast requires balancing membrane permeabilization with epitope preservation:

• Fixative selection:

  • For membrane proteins like SPAC13G7.11, compare 4% paraformaldehyde (preserves structure) with methanol (better for some epitopes).

  • Test dual fixation: brief paraformaldehyde followed by methanol for better penetration.

• Fixation parameters:

  • Temperature: Test both room temperature and 4°C fixation

  • Duration: Compare 10, 20, and 30 minutes

  • Buffer composition: PBS vs. specialized mitochondrial preservation buffers

• Cell wall digestion: For yeast cells, optimize zymolyase concentration (0.5-5 mg/ml) and digestion time (10-30 minutes) to ensure antibody access without damaging mitochondrial structures.

• Permeabilization: Test different detergents (0.1-0.5% Triton X-100, 0.05-0.2% SDS) and times (5-15 minutes) to optimize antibody access to mitochondrial targets.

• Blocking conditions: Compare BSA, normal serum, and commercial blockers at different concentrations to reduce background while preserving specific signal.

Document all conditions systematically to identify the optimal protocol for your specific antibody lot and experimental system .

How can I quantitatively analyze SPAC13G7.11 protein levels across different conditions?

For rigorous quantitative analysis of SPAC13G7.11 protein levels:

• Normalization strategy:

  • Use multiple loading controls: total protein (Ponceau S), housekeeping proteins (actin), and organelle-specific markers (mitochondrial proteins like cox2)

  • For respiratory proteins, normalize to mitochondrial mass using porin/VDAC or citrate synthase

• Quantification methods:

  • Densitometry analysis: Use software like ImageJ with background subtraction

  • Fluorescent Western blotting: Provides wider linear range than chemiluminescence

  • Capillary Western (Jess/Wes systems): Higher reproducibility for quantification

• Statistical analysis:

  • Perform at least 3 biological replicates

  • Use appropriate statistical tests (t-test for simple comparisons, ANOVA for multiple conditions)

  • Report variability measures (SD or SEM)

• Controls for validation:

  • Include known up/downregulating conditions as positive controls

  • Use SPAC13G7.11 knockout strain as negative control

  • Consider spike-in standards for absolute quantification

When comparing expression levels between conditions, account for changes in mitochondrial content or respiratory activity that might affect all mitochondrial proteins .

How can I distinguish between non-specific binding and true interaction partners in SPAC13G7.11 co-immunoprecipitation experiments?

To identify true interaction partners from co-IP experiments with SPAC13G7.11 antibody:

• Essential controls:

  • IgG control: Use matched isotype control antibody for non-specific binding

  • Knockout control: Perform parallel IP in SPAC13G7.11 deletion strain

  • Input normalization: Compare IP efficiency between samples

• Validation approaches:

  • Reciprocal IP: Confirm interactions by IP with antibodies against potential partners

  • Competition assays: Add recombinant SPAC13G7.11 to outcompete specific interactions

  • Gradient fractionation: Verify co-migration of SPAC13G7.11 and partners in native complexes

• Quantitative proteomics:

  • SILAC or TMT labeling: Compare protein enrichment ratios between specific IP and controls

  • Significance analysis: Apply statistical methods to determine significant enrichment

  • Filtering: Use databases of common contaminants to remove background proteins

• Functional validation:

  • Genetic interaction testing: Examine phenotypes of double mutants

  • Proximity labeling: Confirm spatial proximity using BioID or APEX approaches

  • In vitro binding assays: Test direct interactions with purified components

This systematic approach helps distinguish true interactors from background proteins frequently observed in IP-MS experiments .

How can I use SPAC13G7.11 antibody to study its role during different metabolic states?

To investigate how SPAC13G7.11 functions change during metabolic adaptation:

• Experimental setup:

  • Compare fermentative vs. respiratory growth conditions

  • Analyze nutrient starvation responses

  • Examine effects of oxidative stress inducers

  • Monitor during diauxic shift and stationary phase

• Multi-parameter analysis:

  • Protein levels: Western blotting with SPAC13G7.11 antibody

  • Localization: Immunofluorescence with mitochondrial co-markers

  • Complex assembly: Native PAGE followed by immunoblotting

  • PTM status: Phospho-specific detection methods

• Temporal dynamics:

  • Time-course experiments after metabolic shift

  • Pulse-chase analysis of protein turnover

  • Real-time monitoring in live cells with complementary techniques

• Integration with other data:

  • Correlate with respiratory activity measurements

  • Combine with transcriptomics of SPAC13G7.11 and related genes

  • Link to metabolomic changes in relevant pathways

This approach provides comprehensive understanding of how SPAC13G7.11 responds to changing cellular energetic demands .

What are the considerations for using SPAC13G7.11 antibody in cross-species studies?

When using SPAC13G7.11 antibody for comparative studies across species:

• Epitope conservation analysis:

  • Perform sequence alignment of the epitope region across species

  • Predict potential cross-reactivity based on homology

  • Test antibody against recombinant proteins from each species

• Validation in each species:

  • Conduct Western blots with appropriate positive and negative controls

  • Verify band sizes correspond to predicted molecular weights

  • Perform knockout/knockdown validation where possible

• Optimization for each model:

  • Adjust antibody concentration for different species

  • Modify extraction buffers for optimal epitope exposure

  • Adapt immunoprecipitation conditions to species-specific interaction partners

• Interpretative considerations:

  • Account for differences in protein expression levels between species

  • Consider variations in post-translational modifications

  • Recognize differences in protein complex assembly

  • Note functional divergence despite sequence homology

• Human orthologs:

  • The respiratory chain components in humans may share functional homology but differ in structural features

  • Compare results with commercially available antibodies against human orthologs